Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2004

View Archived Issues

Effective cytolysis of Hodgkin's lymphoma tumor cells by antibody-cytokine fusion protein

Phase II study of GDNF for Parkinson's fails to meet primary endpoint

Priority review and accelerated approval designations for Antegren BLA

Aplidin receives orphan drug status for ALL

NX-1207 shows potential as a front-line treatment for BPH in phase I/II trials

FDA accepts IND for MN-029

Fast track status for INO-1001 for patients with STEMI

IND accepted for phase II trials of ORG-25969

Favorable results for ACP-103 for use in Parkinson's patients

Exelixis submits IND for XL-999

Europe's CHMP hands down positive opinion for MabThera in indolent NHL

Bionomics progress in gene test for epilepsy

Retinoic metabolism inhibitors promising against prostate cancer

Novel SERM with minimal ovarian effects

New melatonin receptor ligands prepared and tested by French scientists

Novel modulators of nAChR and monoamine receptors or transporters claimed by NeuroSearch

Servier researchers describe novel cognition-enhancing agents

New IGF-1R inhibitors with potential in cancer therapy

Novel topoisomerase inhibitors identified by researchers at State U. of New Jersey

Novel fusion-targeting antiviral agents presented by Trimeris

New MCH receptor modulators in early development at Tularik

Femara sNDA granted priority review by FDA

Erbitux receives E.U. approval for metastatic colorectal cancer

FDA clears IND for study of VPI-013 in patients with major depressive disorder

IND submission to start phase I trial of thrombin inhibitor ARC-183

Enrollment open in phase III trial of Veronate

Tularik stockholders to meet in August to vote on acquisition by Amgen

Arava approved in Europe for active psoriatic arthritis

Vasopressin V2 receptor antagonist effective aquaretic in vivo

PXD-101 enters phase I trial in hematologic cancer

Exenatide NDA submission for type 2 diabetes

Selective glucocorticoid receptor modulator may prevent progression of multiple sclerosis

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...